GlaxoSmithKline PLC has agreed to pay up to $2.2 billion to settle more than 90% of pending U.S. state court product liability cases involving Zantac. These lawsuits claim that a [...]
The first Zantac trial in California is set to begin soon, with jury selection scheduled for next week in Alameda County Superior Court, Oakland. The trial, Russell v. Boehringer Ingelheim, [...]
As we approach 2025, there is hope for a global resolution in the Paraquat lawsuits. The first trial is scheduled for March in Philadelphia, but Chevron and Syngenta may seek [...]
After a slow couple of months, the Paraquat MDL saw a small increase in November with 17 new cases, bringing the total number of pending cases to 5,835. As we [...]
In October, the Paraquat class action MDL lost 65 cases, reducing the total number of pending cases to 5,818. This marks the second consecutive month of a decrease, with weaker [...]
There is growing expectation that a global Paraquat settlement will be reached within the next six months. While it's not guaranteed, and mass tort lawyers often underestimate settlement timelines, most [...]
The number of cases in the infant formula NEC class action MDL keeps growing steadily. In November, 26 new cases were added, which is the same number as the month [...]
The judge overseeing the NEC formula MDL has scheduled an important in-court status conference for December 19th, which is not very common in such cases. During this conference, several key [...]
To prevent defendants from being wrongly named in NEC lawsuits, the MDL judge has introduced a new rule specifically regarding Mead Johnson & Company. The rule requires that the company [...]
The NEC class action lawsuits in both state and federal courts are progressing, but at a slow pace. However, progress is being made. Plaintiffs believe the stronger cases are solid, [...]
